Treating cancer in patients with Down syndrome presents unique challenges. These individuals often have increased sensitivity to chemotherapy and radiation, which can lead to more severe side effects. Therefore, oncologists must carefully balance treatment efficacy with the potential for adverse reactions. Additionally, the presence of other health conditions commonly associated with Down syndrome, such as congenital heart defects, can complicate cancer treatment.
